CYLD-Mediated Signaling and Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|16|4|284-294

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.4, 2015-04, pp. : 284-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human Fc&unknown;R1 signaling pathway

By Oliver J.M.   Kepley C.L.   Ortega E.   Wilson B.S.  

Immunopharmacology, Vol. 48, Iss. 3, 2000-07 ,pp. : 269-281

Elsevier

Access to resources Recommend Favorite

Kisspeptin Mediated Signaling in Cancer

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 22, 2016-06 ,pp. : 2471-2476

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies for Novel Therapeutic Approaches Targeting Cytokines and Signaling Pathways of Osteoclasto- and Osteoblastogenesis in the Fight Against Immune-Mediated Bone and Joint Diseases

By  

Current Medicinal Chemistry, Vol. 15, Iss. 2, 2008-01 ,pp. : 127-136

Bentham Science Publishers

Access to resources Recommend Favorite

Apoptosis Signaling Pathways in Lung Diseases

By  

Medicinal Chemistry, Vol. 1, Iss. 1, 2005-01 ,pp. : 49-56

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammasome Signaling in Pathogenesis of Lung Diseases

By  

Current Pharmaceutical Design, Vol. 18, Iss. 16, 2012-06 ,pp. : 2320-2328

Bentham Science Publishers

Access to resources Recommend Favorite